Cellectis (CLLS) Gains from Investment Securities (2018 - 2026)
Cellectis (CLLS) recorded quarterly Gains from Investment Securities of $541000.0 in Q1 2026, down 99.76% quarter-over-quarter from $226.0 million in Q4 2024.
Cellectis (CLLS) Gains from Investment Securities (2018 - 2026) Analysis & Trends
Cellectis' Gains from Investment Securities history runs 4 years deep, the most recent figure standing at $541000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities changed N/A year-over-year to $541000.0; the TTM figure through Mar 2026 stood at $226.4 million (changed N/A YoY), while the FY2025 annual figure was -$1000.0, up 95.24% from the prior year.
- Gains from Investment Securities was $541000.0 for Q1 2026 at Cellectis, down from $226.0 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $226.0 million in Q4 2024 to a low of $541000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 541,000.00 |
| Mar 31, 2026 | 541,000.00 |
| Dec 31, 2024 | 225.98 Mn |
| Dec 31, 2024 | 225.98 Mn |
| Dec 31, 2020 | -58,000.00 |
| Dec 31, 2020 | -58,000.00 |
| Sep 30, 2020 | -20,000.00 |
| Sep 30, 2020 | -20,000.00 |
| Jun 30, 2020 | -93,000.00 |
| Jun 30, 2020 | -93,000.00 |
| Mar 31, 2020 | 93,000.00 |
| Mar 31, 2020 | 93,000.00 |
| Dec 31, 2018 | -438,000.00 |
| Dec 31, 2018 | -438,000.00 |